Markets›Health care›MRK

Merck

MRK
148.78
+0.80 (+0.54%)
Closing price for Sep 25, 2026 from Polygon.io

Valuation

Market value367.07B
Enterprise value414.12B
Price to earnings (P/E)118.1
Price to sales5.5
Price to book8.8
Free cash flow yield4.4%

Profitability (last 12 months)

Revenue66.57B
Net income3.17B
Gross margin73.0%
Net margin4.8%
Return on equity7.6%
Return on assets2.4%

Growth (last fiscal year, FY 2025)

Revenue growth+1.3%
EPS growth+8.0%

Balance sheet (latest quarter)

Cash and equivalents6.85B
Total debt53.91B
Debt to equity1.29
Current ratio1.32

Per share and dividends

EPS, diluted (last 12 months)1.26
Shares outstanding2.47B
Dividends paid (last 12 months)None

Trading

Price148.78
52-week high156.92
52-week low78.03
1-year price change+89.34%
Average volume (3 months)9.93M
Beta against the S&P 500 (1 year)0.20

Calculated from Merck's SEC filings (latest quarter ending Jun 30, 2026) and the price above. "Last 12 months" adds up the four most recent quarters. Beta compares one year of daily returns with the S&P 500 (SPY). Dividends from Polygon.io or Nasdaq.